Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids.
File(s) sfw116.pdf (484.86 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Background: There are no prospective randomized controlled trials describing the outcome of acute interstitial nephritis (AIN) treated with steroids, and retrospective studies are limited. Methods: We identified adult patients with a diagnosis of AIN without glomerular pathology over a 14-year period. Treated patients all received oral prednisolone and three also recieved IV methylprednisolone. Data were collected retrospectively on estimated glomerular filtration rate (eGFR), change in eGFR from time of biopsy, dependence on renal replacement therapy (RRT) and mortality, and outcomes were analysed according to the treatment prescribed. Results: A total of 187 eligible patients with AIN were identified and 158 were treated with steroids. There was no difference in median eGFR or dependence on RRT at the time of biopsy. Steroid-treated patients had significantly higher eGFR at all time points post-biopsy up to 24 months, when median eGFR was 43 mL/min in the steroid-treated group and 24 mL/min in the untreated group (P = 0.01). Fewer patients in the steroid-treated group were dialysis dependent by 6 months (3.2% versus 20.6%, P = 0.0022) and 24 months (5.1% versus 24.1%, P = 0.0019). Conclusions: This large retrospective study suggests a benefit of steroids in treatment of AIN with greater improvement in eGFR and fewer patients progressing to end-stage renal disease.
Date Issued
2016-12-24
Date Acceptance
2016-10-03
Citation
Clinical Kidney Journal, 2016, 10 (2), pp.233-239
ISSN
2048-8505
Publisher
Oxford University Press
Start Page
233
End Page
239
Journal / Book Title
Clinical Kidney Journal
Volume
10
Issue
2
Copyright Statement
© 2016 The Author(s). Published by Oxford University Press on behalf of ERA-EDTA.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact journals.permissions@oup.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact journals.permissions@oup.com
Sponsor
Imperial College Healthcare NHS Trust- BRC Funding
Identifier
http://www.ncbi.nlm.nih.gov/pubmed/28396740
PII: sfw116
Grant Number
RDA04 79560
Subjects
acute interstitial nephritis
renal pathology
steroid therapy
Publication Status
Published
Coverage Spatial
England
